Handle survivors with care

New England Journal of Medicine

Volumn 377, Issue 15, 2017, Pages 1480-1482

  Sprecher, Armand ^a  

^a MÉDECINS SANS FRONTIÈRES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EDITORIAL; GENOMICS; HEALTH CARE SYSTEM; HUMAN; IMMUNOGENICITY; MARBURG HEMORRHAGIC FEVER; PATIENT CARE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL-BEING; RISK ASSESSMENT; RISK FACTOR; SAFETY; SEX DIFFERENCE; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SURVIVOR; NEOPLASM;

HUMANS; NEOPLASMS; SURVIVORS;

EID: 85031013700     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1512928     Document Type: Editorial

References (14)

1. Martini GA, Schmidt HA. Spermatogenic transmission of the “Marburg virus” (causes of “Marburg simian disease”). Klin Wochenschr 1968;46:398-400. (In German.)
2. Christie A, Davies-Wayne GJ, Cordier-Lassalle T, et al. Possible sexual transmission of Ebola virus — Liberia, 2015. MMWR Morb Mortal Wkly Rep 2015;64:479-81.
3. Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med 2015; 373:2448-54.
4. Rodriguez LL, De Roo A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179: Suppl 1:S170-S176.
5. Deen GF, Broutet N, Xu W, et al. Ebola RNA persistence in semen of Ebola virus disease survivors — final report. N Engl J Med 2017;377:1428-37.
6. World Health Organization. Ebola situation report — 30 March 2016 (http://apps.who.int/ebola/current-situation/ebola-situation-report-30-march-2016).
7. Alpren C, Sloan M, Boegler KA, et al. Notes from the field: Ebola virus disease cluster — northern Sierra Leone, January 2016. MMWR Morb Mortal Wkly Rep 2016;65:681-2.
8. Diallo B, Sissoko D, Loman NJ, et al. Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis 2016;63:1353-6.
9. World Health Organization. Criteria for declaring the end of the Ebola outbreak in Guinea, Liberia or Sierra Leone. 2015 (http://www.who.int/csr/disease/ebola/declaration-ebola-end/en/).
10. Mayrhuber EA, Niederkrotenthaler T, Kutalek R. “We are survivors and not a virus:” Content analysis of media reporting on Ebola survivors in Liberia. PLoS Negl Trop Dis 2017;11(8): e0005845.
11. Doucleff M. India quarantines Ebola survivor because of infectious semen. NPR. November 18, 2014 (http://www.npr.org/sections/goatsandsoda/2014/11/18/365015169/india-quarantines-ebola-survivor-because-of-infectious-semen).
12. Ruble K. Ebola survivors face stigma and harsh punishment for having sex in Sierra Leone. Vice News. March 2, 2015 (https://news.vice.com/article/ebola-survivors-face-stigma-and-harsh-punishment-for-having-sex-in-sierra-leone).
13. Kennedy SB, Bolay F, Kieh M, et al. Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia. N Engl J Med 2017;377:1438-47.
14. Henao-Restrepo AM, Longini IM, Egger M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015;386:857-66.